Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

Study on the Correlation Between Fat Soluble Vitamins and Non-alcoholic Fatty Liver Disease

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Excessive or insufficient levels of vitamins in the body can affect health. With the prevalence of obesity and MetS, NAFLD has become the leading cause of chronic liver disease and abnormal liver biochemical indicators in health examinations in China. The current research results on serum vitamin A, D, and E levels in NAFLD patients are controversial. Therefore, this study mainly explores the correlation between serum FSV levels and NAFLD, providing reference for nutrition and clinical management of NAFLD patients.

Who May Be Eligible (Plain English)

Who May Qualify: 1. Age ≥ 18 years old, both male and female; 2. Voluntarily participate in this study and sign an willing to sign a consent form form; 3. Diagnosed NAFLD through abdominal ultrasound; Who Should NOT Join This Trial: 1. Acute and chronic infections, severe cardiovascular and cerebrovascular diseases, respiratory system diseases, urinary system diseases, rheumatic diseases, tumors, and pituitary dysfunction; Or have hepatitis B, hepatitis C virus, or acquired weakened immune system syndrome; 2. Surgery was performed within 6 months, and blood donation, transfusion, or significant blood loss occurred within 4 months; 3. Have taken vitamin supplements within 2 weeks; 4. Women are in pregnancy, lactation, or within one year after childbirth; 5. Alcohol abuse (alcohol intake ≥ 140 g/week for males and ≥ 70 g/week for females) 6. The serum creatinine (SCr) exceeds twice the following abnormal values, with the standard of abnormal values being: male (20-59 years old)\>97 μ mol/L, male (60-79 years old)\>111 μ mol/L; Female (20-59 years old)\>73 μ mol/L, female (60-79 years old)\>81 μ mol/L. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: 1. Age ≥ 18 years old, both male and female; 2. Voluntarily participate in this study and sign an informed consent form; 3. Diagnosed NAFLD through abdominal ultrasound; Exclusion Criteria: 1. Acute and chronic infections, severe cardiovascular and cerebrovascular diseases, respiratory system diseases, urinary system diseases, rheumatic diseases, tumors, and pituitary dysfunction; Or have hepatitis B, hepatitis C virus, or acquired immunodeficiency syndrome; 2. Surgery was performed within 6 months, and blood donation, transfusion, or significant blood loss occurred within 4 months; 3. Have taken vitamin supplements within 2 weeks; 4. Women are in pregnancy, lactation, or within one year after childbirth; 5. Alcohol abuse (alcohol intake ≥ 140 g/week for males and ≥ 70 g/week for females) 6. The serum creatinine (SCr) exceeds twice the following abnormal values, with the standard of abnormal values being: male (20-59 years old)\>97 μ mol/L, male (60-79 years old)\>111 μ mol/L; Female (20-59 years old)\>73 μ mol/L, female (60-79 years old)\>81 μ mol/L.

Treatments Being Tested

OTHER

This study is an observational study without any intervention measures.

Locations (1)

First Affiliated Hospital of Zhejiang University
Hangzhou, Zhejiang, China